Page last updated: 2024-10-26

pentetic acid and Cystadenocarcinoma, Serous

pentetic acid has been researched along with Cystadenocarcinoma, Serous in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Cystadenocarcinoma, Serous: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)

Research Excerpts

ExcerptRelevanceReference
" The pharmacokinetic study showed a retention half-life of 25."1.29Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer. ( Bardiès, M; Chatal, JF; Faivre-Chauvet, A; Imai, S; Kraeber-Bodéré, F; Le Boterff, J; Mishra, A; Thédrez, P, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kraeber-Bodéré, F1
Mishra, A1
Thédrez, P1
Faivre-Chauvet, A1
Bardiès, M1
Imai, S1
Le Boterff, J1
Chatal, JF1
Nguyen, BD1
Regan, F1

Other Studies

2 other studies available for pentetic acid and Cystadenocarcinoma, Serous

ArticleYear
Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:5

    Topics: Animals; Cystadenocarcinoma, Serous; Female; Humans; Isothiocyanates; Isotope Labeling; Mice; Mice,

1996
In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
    Clinical nuclear medicine, 1997, Volume: 22, Issue:4

    Topics: Adult; Antibodies, Monoclonal; Cystadenocarcinoma, Serous; Female; Humans; Indium Radioisotopes; Oli

1997